News
4317 posts · page 9 of 180

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a key player in cancer scan chemicals.

Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Amid IPO Success
Molbio Diagnostics posts Rs 52.74 crore profit in Q1, reversing last year's loss. Truenat test-kit sales boost revenue.

Indian AI Platform for Cancer Care Gains BRICS Recognition
iOncology.ai, a collaborative AI platform for cancer care, is highlighted in the BRICS Health Journal, underscoring its potential in emerging economies.

Waystar Considers Sale Amid Falling Market Value, Sources Reveal
Waystar, a healthcare software firm, is exploring a potential sale after a 24% stock slide, sources say.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences, enhancing its diagnostics division.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics swings to Rs 52.7 crore profit in Q1, driven by Truenat test-kit sales.

Indian AI Platform for Cancer Care Gains Spotlight in BRICS Journal
iOncology.ai, an AI platform from AIIMS and C-DAC, is featured in a BRICS journal for its potential to transform cancer care in emerging economies.

Waystar Considers Sale Amidst Declining Market Value
Healthcare software firm Waystar may return to private ownership, considering a sale amid falling stock prices.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, a firm specializing in cancer scan chemicals.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing a Rs 23.94 crore loss from the previous year.

Indian AI Platform iOncology.ai Gains Recognition in BRICS Health Journal
The AI-powered iOncology.ai platform, developed by AIIMS and C-DAC, was spotlighted in the BRICS Health Journal for its potential to transform cancer care.

Healthcare Software Firm Waystar Contemplates Sale Amid Market Challenges
Waystar considers strategic options, including a potential sale, after a 24% stock slump this year.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences, a radiopharmaceutical firm.

Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1, Surpassing Previous Loss
Molbio Diagnostics, listed in August, posts Rs 52.7 cr profit in Q1, rebounding from last year's loss.

Indian AI Cancer Care Platform Highlighted in BRICS Health Journal
iOncology.ai, an AI-based cancer care platform from India, gains global attention at the BRICS Summit.

Waystar Explores Strategic Options Amid Market Challenges: Sources
Healthcare software firm Waystar is considering a sale amid declining market value and AI concerns, sources reveal.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences: FT Report
GE HealthCare is reportedly negotiating a $1 billion deal to acquire Sofie Biosciences, enhancing its diagnostics capabilities.

Molbio Diagnostics Sees Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics reports a Rs 52.7 crore profit in Q1, a stark contrast to last year's loss.

Indian AI Platform iOncology.ai Showcased at BRICS Health Summit
iOncology.ai, an AI-driven cancer care platform, was highlighted at the BRICS Health Summit, emphasizing its potential to transform cancer care in emerging economies.

Waystar Considers Sale Amid Market Challenges, Sources Reveal
Waystar, a healthcare software firm, is exploring a potential sale after a sharp stock decline.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, which could enhance its cancer diagnostics capabilities.

Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Post-IPO Quarter
Molbio Diagnostics sees a turnaround with Rs 52.7 crore profit in Q1, driven by Truenat test-kit sales.

Indian AI Cancer Platform iOncology.ai Shines at BRICS Summit
iOncology.ai, an Indian AI platform for cancer care, gains international attention at the BRICS Summit, featured in a special edition of the BRICS Health Journal.

Waystar Considers Sale Amid Falling Market Value, Sources Reveal
Healthcare software firm Waystar is evaluating strategic options, including a potential sale, following a stock decline.
